Fecal microbiota transplantation as an effective way in treating methylmercury-poisoned rats

Yanfei Zhang1, Qingxuan Liu1, Hongxin Xie2

  • 1Jilin Medical University, Jilin 132013, Jilin, China.

PubMed

Insights

Fecal microbiota transplantation (FMT) improved neurological disorders and mercury levels in methylmercury-poisoned rats. FMT also restored gut microbiome balance and promoted beneficial metabolites, offering potential treatments for neurotoxic conditions.

Area of Science:

  • Neuroscience
  • Toxicology
  • Microbiology

Background:

  • Methylmercury (MeHg) causes severe neurotoxicity.
  • Gut microbiota dysbiosis is linked to MeHg poisoning.
  • Fecal microbiota transplantation (FMT) shows therapeutic potential in various neurological diseases.

Purpose of the Study:

  • To investigate the therapeutic effects of FMT on methylmercury-poisoned rats.
  • To evaluate neurobehavioral changes, mercury levels, and gut microbiome alterations post-FMT.

Main Methods:

  • Administered FMT to MeHg-poisoned rats for 14 days.
  • Assessed neurobehavior, weight changes, dopamine levels, and mercury concentrations (total Hg and MeHg).
  • Analyzed fecal gut microbiota composition and metabolite profiles.

Main Results:

  • FMT treatment led to significant weight gain and alleviated neurological deficits in MeHg-poisoned rats.
  • Enhanced fecal mercury excretion and MeHg demethylation were observed after FMT.
  • FMT reconstructed the gut microbiome and promoted the production of gut-brain axis-related metabolites.

Conclusions:

  • Fecal microbiota transplantation demonstrates significant therapeutic efficacy in mitigating methylmercury-induced neurotoxicity in rats.
  • FMT normalizes gut microbiota, enhances mercury detoxification, and improves neurological function.
  • This study provides a basis for exploring FMT as a treatment for methylmercury poisoning and related neurological disorders like Minamata and Parkinson's diseases.

Related Concept Videos